| Management target | Revenue 16.0% 2030 |
|---|
| Margins | Banking margins flat despite higher loan volumes. |
|---|---|
| Demand visibility | High demand for multi-rail payments and alternative lending. |
Growth
Projected card payments of ZAR 2.9Tn in 2025; online retail to exceed R150Bn by 2026.
Outlook
Open banking CAGR ~28.7% by 2030; embedded finance market projected to reach $5.55Bn by 2030.
Risks
Digital-banking fraud up 86%; SME credit gap exceeds R350Bn; significant regulatory pressure (COFI, POPIA).
Last quarter's promises, checked
Delivered
- EBITDA margin mid-teens → delivered 15.4% (= BEAT)
- Voluntary attrition below 10% → delivered 9.8% (= BEAT)
- Utilisation increase → delivered 84.8% up 50bps QoQ (= BEAT)
Partly delivered
- Absorb salary hike impact → delivered margin expansion but revenue growth stalled (= PARTIAL)
Missed
- Aspire for double-digit growth in FY26 → delivered 0.5% QoQ revenue (= MISS)
- TMT worst behind us (Q1 claim) → delivered -9.9% QoQ decline (= MISS)
Earnings Call Transcript filed with BSE, NSE: ZENSARTECH. Summary written with AI assistance from the document.
Zensar Technologies Ltd: key numbers
- Share price
- ₹439.30
- Market cap
- ₹9,998 Cr
- Revenue (annual)
- ₹5,687 Cr
- Net profit (annual)
- ₹774.6 Cr
- P/E (TTM)
- 12.9×Sector 21.6×
- Promoter holding
- 48.99%-0.01% QoQ
- FII holding
- 10.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zensar Technologies Ltd
All →Zensar Technologies Credit Rating
ICRA Limited has reaffirmed the credit rating of Zensar Technologies for its long-term and short-term fund/non-fund based bank facilities, totaling ₹191 Crore.
- Value
- ₹191.0 Cr
Zensar Technologies Employee Stock Options
Designated person Vijayasimha Alilughatta acquired 8,983 shares of Zensar Technologies through an ESOP exercise. The transaction is valued at ₹0.43 Crore.
- Value
- ₹0.43 Cr
Zensar Technologies Employee Stock Options
Zensar Technologies has allotted 25,691 equity shares to employees following the exercise of their vested ESOPs.
Zensar Technologies Other Announcement
Zensar Technologies Ltd has filed its quarterly shareholding pattern for the period ended December 31, 2025, in compliance with regulatory requirements.
Zensar Technologies Merger & Restructuring
Zensar Technologies announced the completed merger of its US subsidiaries M3BI LLC and Bridgeview Life Sciences LLC into Zensar Technologies Inc. The mergers become effective September 1, 2026.
- Execution
- Effective September 1, 2026
Zensar Technologies Other Announcement
Zensar Technologies Limited has received an independent ESG score of 74 from Crisil ESG Ratings & Analytics Limited, categorizing the company under 'Leadership' for FY2026.